130 likes | 139 Views
The global synthetic biology market is projected to reach USD 8.84 Billion by 2022 from USD 3.57 Billion in 2017, at a CAGR of 19.9%. This high growth rate can be attributed to the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Factors such as rising concerns regarding fuel consumption and increasing demand for protein therapeutics are expected to offer lucrative opportunities for players in the global market.<br><br>In this report, the global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes.<br><br>By technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the global market in technology. This is attributed to the fact that the technology is used in a wide range of applications such as producing vaccines, engineering enzymes to restrict cancer growth, producing sustainable biofuels, improving crop yield, and detecting and breaking down environmental pollutants in the soil, air, and water offered by gene synthesis.
E N D
MarketsandMarkets Presents The Impact of the Different Market Factors on Synthetic Biology Market https://www.marketsandmarkets.com/Market-Reports/varicose-vein-treatment-market-22524107.html
The report "Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", Browse 162 market data Tables and 32 Figures spread through 214 Pages and in-depth TOC on "Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022” https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
Early buyers will receive 10% customization on this report. https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
The global synthetic biology market is projected to reach USD 8.84 Billion by 2022 from USD 3.57 Billion in 2017, at a CAGR of 19.9%. This high growth rate can be attributed to the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Factors such as rising concerns regarding fuel consumption and increasing demand for protein therapeutics are expected to offer lucrative opportunities for players in the global market. • In this report, the global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes. https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
By technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the global market in technology. This is attributed to the fact that the technology is used in a wide range of applications such as producing vaccines, engineering enzymes to restrict cancer growth, producing sustainable biofuels, improving crop yield, and detecting and breaking down environmental pollutants in the soil, air, and water offered by gene synthesis. https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
The synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application. The pharmaceuticals subsegment is expected to account for the largest share of the market. However, biofuel and renewable energy is expected to grow at the highest CAGR during the forecast period owing to the global demand for fossil fuel alternatives and the advantages of the genetically engineered organisms for the synthetic production of biofuels • Based on region, the synthetic biology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global market. Regarding growth rate, Europe is expected to register the highest growth rate from 2017 to 2022. Factors such as increasing investments for the adoption of adoption of novel synthetic biology technologies, rising R&D funding and collaborations are driving the growth of the market in this region. https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
The global synthetic biology market was valued at USD 3.02 Billion in 2016 and is expected to grow at a CAGR of 19.9% during the forecast period to reach to USD 8.84 Billion by 2022. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. • Objectives of the Study • To define, describe, and forecast the global market by tools, technologies, applications, and region • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges) • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders • To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World • To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials • To track and analyze competitive developments such as collaborations, partnerships, and agreements; expansions; product launches; acquisitions; and other developments in the synthetic biology market https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
Research Methodology • Top-down and bottom-up approaches were used to validate the size of the synthetic biology market and estimate the size of other dependent submarkets. Various secondary sources such as Centre for Synthetic Biology and Innovation (CSynBI), Institute of Systems and Synthetic Biology, University of California San Francisco (UCSF) Center for Systems & Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Synthetic Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Industry Association of Synthetic Biology (IASB), European association of synthetic biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Biological Sciences Research Council, expert interviews, and MarketsandMarketsAnalysishave been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below: https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
The major players in the global synthetic biology market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US). https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html